Company / Book Value per Share
Xeris Biopharma Holdings, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.092
FY2025
5-year range
-$0.214 / $2.233
FY2021-FY2025
Trend
+142.7%
vs FY2024
Sector context
#186 of 209
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s book value per share of $0.092 is lower than 89% of companies in the Health Care sector (FY2025). Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $0.092.
Based on SEC 10-K filings.
$0.092 in FY2025 with a 5-year CAGR of -35.0%.
Improved from -$0.05 to $0.092 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -30.3%
- 5-Year CAGR
- -35.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 209This company $0.092 Sector average $189.406
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -35.0%, indicating a declining trend.
- In FY2025, book value per share increased 142.7% year-over-year.
- Ranks #186 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.092 | +142.7% |
| FY2024 | -$0.214 | -330.8% |
| FY2023 | -$0.05 | -118.4% |
| FY2022 | $0.27 | -87.9% |
| FY2021 | $2.233 | +182.1% |
| FY2020 | $0.792 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026